Literature DB >> 26071838

LRP4 in neuromuscular junction and bone development and diseases.

Chengyong Shen1, Wen-Cheng Xiong1, Lin Mei2.   

Abstract

Low-density lipoprotein receptor-related protein 4 (LRP4) is a member of the low-density lipoprotein receptor (LDLR) family. Recent studies have revealed multiple functions and complex signaling mechanisms of LRP4 in different organs and tissues. LPR4 mutation or malfunction has been implicated in neurological disorders including congenital myasthenic syndrome, myasthenia gravis, and diseases of bone or kidney. This article is part of a Special Issue entitled "Muscle Bone Interactions".
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bone; Low-density lipoprotein receptor-related protein 4; Myasthenia gravis; Neuromuscular junction

Mesh：

Substances：

Year:  2015        PMID： 26071838     DOI： 10.1016/j.bone.2015.05.012

Source DB:  PubMed          Journal:  Bone        ISSN： 1873-2763            Impact factor:   4.398


  19 in total

1.  Agrin to YAP in Cancer and Neuromuscular Junctions.

Authors:  Wen-Cheng Xiong; Lin Mei
Journal:  Trends Cancer       Date:  2017-03-28

Review 2.  Low-Density Lipoprotein Receptor-Related Proteins in Skeletal Development and Disease.

Authors:  Tao Yang; Bart O Williams
Journal:  Physiol Rev       Date:  2017-07-01       Impact factor: 37.312

3.  Exome sequencing of two Italian pedigrees with non-isolated Chiari malformation type I reveals candidate genes for cranio-facial development.

Authors:  Elisa Merello; Lorenzo Tattini; Alberto Magi; Andrea Accogli; Gianluca Piatelli; Marco Pavanello; Domenico Tortora; Armando Cama; Zoha Kibar; Valeria Capra; Patrizia De Marco
Journal:  Eur J Hum Genet       Date:  2017-05-17       Impact factor: 4.246

Review 4.  Mechanisms of Autoantibody-Induced Pathology.

Authors:  Ralf J Ludwig; Karen Vanhoorelbeke; Frank Leypoldt; Ziya Kaya; Katja Bieber; Sandra M McLachlan; Lars Komorowski; Jie Luo; Otavio Cabral-Marques; Christoph M Hammers; Jon M Lindstrom; Peter Lamprecht; Andrea Fischer; Gabriela Riemekasten; Claudia Tersteeg; Peter Sondermann; Basil Rapoport; Klaus-Peter Wandinger; Christian Probst; Asmaa El Beidaq; Enno Schmidt; Alan Verkman; Rudolf A Manz; Falk Nimmerjahn
Journal:  Front Immunol       Date:  2017-05-31       Impact factor: 7.561

5.  Multiple modes of Lrp4 function in modulation of Wnt/β-catenin signaling during tooth development.

Authors:  Youngwook Ahn; Carrie Sims; Megan J Murray; Paige K Kuhlmann; Jesús Fuentes-Antrás; Scott D Weatherbee; Robb Krumlauf
Journal:  Development       Date:  2017-07-10       Impact factor: 6.868

6.  A Role of Low-Density Lipoprotein Receptor-Related Protein 4 (LRP4) in Astrocytic Aβ Clearance.

Authors:  Hongsheng Zhang; Wenbing Chen; Zhibing Tan; Lei Zhang; Zhaoqi Dong; Wanpeng Cui; Kai Zhao; Hongsheng Wang; Hongyang Jing; Rangjuan Cao; Chae Kim; Jiri G Safar; Wen-Cheng Xiong; Lin Mei
Journal:  J Neurosci       Date:  2020-05-26       Impact factor: 6.167

7.  Mutations in the fourth β-propeller domain of LRP4 are associated with isolated syndactyly with fusion of the third and fourth fingers.

Authors:  Rivka Sukenik Halevy; Huan-Chieh Chien; Bo Heinz; Michael J Bamshad; Deborah A Nickerson; Martin Kircher; Nadav Ahituv
Journal:  Hum Mutat       Date:  2018-03-22       Impact factor: 4.878

Review 8.  LRPs in WNT Signalling.

Authors:  Gary Davidson
Journal:  Handb Exp Pharmacol       Date:  2021

9.  The extracellular matrix protein Agrin is expressed by osteoblasts and contributes to their differentiation.

Authors:  Alann Thaffarell Portilho Souza; Helena Bacha Lopes; Fabiola Singaretti Oliveira; Denise Weffort; Gileade Pereira Freitas; Leticia Faustino Adolpho; Roger Rodrigo Fernandes; Adalberto Luiz Rosa; Marcio Mateus Beloti
Journal:  Cell Tissue Res       Date:  2021-07-05       Impact factor: 5.249

10.  Characterization of LRP4/Agrin Antibodies From a Patient With Myasthenia Gravis.

Authors:  Zheng Yu; Meiying Zhang; Hongyang Jing; Peng Chen; Rangjuan Cao; Jinxiu Pan; Bin Luo; Yue Yu; Brandy M Quarles; Wencheng Xiong; Michael H Rivner; Lin Mei
Journal:  Neurology       Date:  2021-07-07       Impact factor: 11.800
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.